Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Extracell Vesicles ; 11(1): e12176, 2022 01.
Article in English | MEDLINE | ID: mdl-34973063

ABSTRACT

Natural killer (NK) cells are innate cytotoxic lymphocytes that play a key role in cancer immunosurveillance thanks to their ability to recognize and kill cancer cells. NKG2D is an activating receptor that binds to MIC and ULBP molecules typically induced on damaged, transformed or infected cells. The release of NKG2D ligands (NKG2DLs) in the extracellular milieu through protease-mediated cleavage or by extracellular vesicle (EV) secretion allows cancer cells to evade NKG2D-mediated immunosurveillance. In this work, we investigated the immunomodulatory properties of the NKG2D ligand MICA*008 associated to distinct populations of EVs (i.e., small extracellular vesicles [sEVs] and medium size extracellular vesicles [mEVs]). By using as model a human MICA*008-transfected multiple myeloma (MM) cell line, we found that this ligand is present on both vesicle populations. Interestingly, our findings reveal that NKG2D is specifically involved in the uptake of vesicles expressing its cognate ligand. We provide evidence that MICA*008-expressing sEVs and mEVs are able on one hand to activate NK cells but, following prolonged stimulation induce a sustained NKG2D downmodulation leading to impaired NKG2D-mediated functions. Moreover, our findings show that MICA*008 can be transferred by vesicles to NK cells causing fratricide. Focusing on MM as a clinically and biologically relevant model of tumour-NK cell interactions, we found enrichment of EVs expressing MICA in the bone marrow of a cohort of patients. All together our results suggest that the accumulation of NKG2D ligands associated to vesicles in the tumour microenvironment could favour the suppression of NK cell activity either by NKG2D down-modulation or by fratricide of NK cell dressed with EV-derived NKG2D ligands.


Subject(s)
Extracellular Vesicles/immunology , Histocompatibility Antigens Class I/immunology , Immunologic Surveillance , Killer Cells, Natural/immunology , Multiple Myeloma/immunology , Aged , Aged, 80 and over , Bone Marrow/immunology , Cell Death/immunology , Cell Line , Extracellular Signal-Regulated MAP Kinases/metabolism , Female , Humans , Immunomodulation , Interferon-gamma/metabolism , Ligands , Male , Middle Aged , NK Cell Lectin-Like Receptor Subfamily K/immunology , Tumor Escape
2.
Oncoimmunology ; 6(3): e1279372, 2017.
Article in English | MEDLINE | ID: mdl-28405503

ABSTRACT

Exosomes are a class of nanovesicles formed and released through the late endosomal compartment and represent an important mode of intercellular communication. The ability of anticancer chemotherapy to enhance the immunogenic potential of malignant cells mainly relies on the establishment of the immunogenic cell death (ICD) and the release of damage-associated molecular patterns (DAMPs). Here, we investigated whether genotoxic stress could promote the release of exosomes from multiple myeloma (MM) cells and studied the immunomodulatory properties they exert on NK cells, a major component of the antitumor immune response playing a key role in the immunosurveillance of MM. Our findings show that melphalan, a genotoxic agent used in MM therapy, significantly induces an increased exosome release from MM cells. MM cell-derived exosomes are capable of stimulating IFNγ production, but not the cytotoxic activity of NK cells through a mechanism based on the activation of NF-κB pathway in a TLR2/HSP70-dependent manner. Interestingly, HSP70+ exosomes are primarily found in the bone marrow (BM) of MM patients suggesting that they might have a crucial immunomodulatory action in the tumor microenvironment. We also provide evidence that the CD56high NK cell subset is more responsive to exosome-induced IFNγ production mediated by TLR2 engagement. All together, these findings suggest a novel mechanism of synergism between chemotherapy and antitumor innate immune responses based on the drug-promotion of nanovesicles exposing DAMPs for innate receptors.

3.
Int J Mol Med ; 22(1): 17-23, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18575771

ABSTRACT

Venous leg ulcers are an important medical issue due to their high incidence in the elderly and the lack of a standard curative approach. Apart from surgical therapy, different medical treatments to effect ulcer wound repair and regeneration are currently being investigated. Sucralfate is a cytoprotective agent employed to prevent or treat several gastrointestinal diseases such as gastroesophageal reflux, gastritis, peptic ulcer, stress ulcer and dyspepsia. In this study we evaluated the efficacy, safety and tolerability of topical sucralfate (SUC-LIS 95) on the healing of chronic venous leg ulcers in 50 patients by a double-blind, placebo-controlled, randomized study. Our results indicated that the daily application of SUC-LIS 95 to non-infected post-phlebitis/vascular ulcers, for a median period of 42.0 days, led to complete healing in 95.6% of patients, against only 10.9% of cases with a matched placebo. A significant improvement was obtained in the SUC-LIS 95-treated patient group with regard to local tissue inflammation as well as pain and burning, and consequently, in ulcer size and the evolution of granulation tissue. Our findings were corroborated for selected patients by the morphological analysis of biopsies obtained before and after treatment. Using ultrastructural analysis we demonstrated that the topical use of SUC-LIS 95 was able to affect neoangiogenesis, increase wound contraction, promote re-epithelialization of the wound area and diminish the inflammatory reaction. Overall, our results indicated that patients with chronic venous ulcers show improvement after the use of topical sucralfate.


Subject(s)
Sucralfate/administration & dosage , Sucralfate/therapeutic use , Varicose Ulcer/drug therapy , Administration, Topical , Aged , Chronic Disease , Demography , Female , Humans , Male , Middle Aged , Placebos , Sucralfate/pharmacology , Varicose Ulcer/pathology , Wound Healing/drug effects
4.
Int J Oncol ; 27(4): 1005-11, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16142317

ABSTRACT

The expression of the extracellular matrix-related genes, such as fibronectin, laminin and tenascin C, and apoptosis-related genes, such as bax, bcl2 and survivin, was evaluated by reverse transcription-polymerase chain reaction (RT-PCR) and by immunohistochemistry in normal breast tissue and benign and malignant breast tumors and then correlated to several clinical parameters: estrogen and progesterone receptors, Ki67, ErbB2, tumor size, lymph node status and grading. Seventy-three breast tissue samples were examined. After RNA extraction, an RT-PCR was performed to detect fibronectin, laminin, tenascin C, bax, bcl2 and survivin gene expression. Thirty-two samples were evaluated also by immunohistochemistry at the protein level to detect fibronectin, laminin, tenascin C, bax and survivin. We found a significant correlation (P=0.025) between fibronectin gene expression and lymph node status, and a significant negative correlation (P=0.049) between laminin gene expression and Ki67. In addition, we found a statistically significant increase in survivin transcription in malign tumors compared to fibroadenomas (P=0.024). The negative correlation between laminin transcription and Ki67 could suggest that laminin impacts negatively on tumor proliferation, and the positive correlation between fibronectin and lymph node status may lead to consider fibronectin as predictive of long distance metastasis.


Subject(s)
Apoptosis , Biomarkers, Tumor , Breast Diseases/metabolism , Breast Neoplasms/metabolism , Carcinoma/metabolism , Extracellular Matrix/metabolism , Gene Expression Regulation, Neoplastic , Gene Expression Regulation , Cell Differentiation , Cell Line, Tumor , Cell Proliferation , Cytoplasm/metabolism , Female , Fibronectins/metabolism , Humans , Immunohistochemistry , Inhibitor of Apoptosis Proteins , Ki-67 Antigen/biosynthesis , Laminin/metabolism , Lymphatic Metastasis , Microtubule-Associated Proteins/metabolism , Neoplasm Metastasis , Neoplasm Proteins/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , RNA/metabolism , Receptor, ErbB-2/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Survivin , Tenascin/metabolism , bcl-2-Associated X Protein/metabolism
5.
Mol Cell Biochem ; 252(1-2): 73-81, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14577578

ABSTRACT

The cardiomyopathic hamster is characterized by a naturally occurring deletion in the delta-sarcoglycan gene generating either the hypertrophic or the dilatative phenotype of cardiomyopathy. This evidence suggests that other genetic or environmental factors might concur to the pathogenesis of cardiomyopathy. The aim of the present study was to investigate on the possibility that other genes are involved in the pathogenesis of hamster cardiomyopathy. For this purpose, a series of genes of cardiomyopathic and healthy hamsters were compared by the differential display technique. The hamster cytochrome c oxidase mitochondrial subunit III (COIII) gene has been sequenced and identified as the gene upregulated in brain and skeletal muscle. The gene sequencing and restriction analysis demonstrated that a missense mutation is present in the COIII gene of hamsters exhibiting hypertrophic cardiomyopathy while no mutations were present in dilatative cardiomyopathic hamsters. The mutation was heteroplasmic and the heteroplasmy level was increased with age in skeletal muscle and heart. The ultrastructural analysis of cardiac tissue showed severe damage in the mitochondrial structure of hypertrophic but not dilatative hamster hearts. These results suggest that the pathogenesis of the cardiac damage in hypertrophic cardiomyopathic hamster may be sustained by multiple mutations exerting a cumulative effect on both structure and function of cardiac muscle.


Subject(s)
Cardiomegaly/genetics , DNA, Mitochondrial/genetics , Mutation, Missense , Amino Acid Sequence , Animals , Base Sequence , Blotting, Northern , Cloning, Molecular , Cricetinae , DNA Primers , DNA, Complementary , Electron Transport Complex IV/genetics , In Situ Hybridization , Mitochondria, Heart/enzymology , Molecular Sequence Data , Sequence Homology, Amino Acid , Sequence Homology, Nucleic Acid
6.
Oncol Rep ; 9(1): 205-9, 2002.
Article in English | MEDLINE | ID: mdl-11748484

ABSTRACT

The effects of retinoic acid (RA) on cell replication, fibronectin and laminin synthesis, integrin expression and haptotactic migration of three mesothelioma cell cultures of different histotype, one epithelioid, one fibromatous and one biphasic, were evaluated. Cell growth was not affected by RA, while RA treatment decreased the synthesis of fibronectin and laminin and inhibited the migration of all three mesotheliomas on substrates of fibronectin and laminin; on the contrary, the expression of some integrins was not significantly modified by RA. These data indicate that RA may lead to a decrease of mesothelioma cell local invasion; this can correlate with a modification induced by RA on mesothelioma tumor progression in vivo.


Subject(s)
Antineoplastic Agents/pharmacology , Cell Movement/drug effects , Fibronectins/antagonists & inhibitors , Laminin/antagonists & inhibitors , Mesothelioma/pathology , Pleural Neoplasms/pathology , Tretinoin/pharmacology , Cell Adhesion/drug effects , Cell Division/drug effects , Epithelioid Cells/metabolism , Fibronectins/biosynthesis , Humans , Laminin/biosynthesis , Mesothelioma/metabolism , Pleural Neoplasms/metabolism , Tumor Cells, Cultured/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...